Pacific Biosciences shares surge 13.38% intraday as genomics market growth report and Stephens price target raise to $2.00 drive optimism.
ByAinvest
Thursday, Nov 20, 2025 10:32 am ET1min read
PACB--
Pacific Biosciences surged 13.38% intraday trading as a November 20, 2025, report projected the global genomics market to grow from $47.07 billion in 2025 to $85.09 billion by 2030 at a 12.6% CAGR, highlighting strong industry growth. The company also participated in the Stephens annual investment conference and Jefferies Global Healthcare Conference on November 19, 2025, and Stephens raised its price target to $2.00 from $1.80, reflecting bullish expectations.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet